Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Clopid vs Plavix 75 mg
NCT05186129Phase 1Completed
- Sponsor
- Center for Bioequivalence Studies and Clinical Research
- Start
- Apr 2018
- Primary completion
- Apr 2018
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of clopidogrel in atherothrombosis, sponsored by Center for Bioequivalence Studies and Clinical Research. Started Apr 2018; status: completed.
02
Drugs
clopidogrel
03
Conditions
atherothrombosis
Beyond the preview
Go deeper on NCT05186129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05186129.